Meeting Banner
Abstract #3187

Magnetic Resonance Spectroscopy Identifies Endothelial Growth Factor Receptor Amplification in High-Grade Gliomas.

Bas Idema1, Sandra Sprenger2, Judith Jeuken2, 3, Andre Grotenhuis1, Pieter Wesseling2, Arend Heerschap4

1Neurosurgery, UMC St Radboud, Nijmegen, Gelderland, Netherlands; 2Pathology, UMC St Radboud, Nijmegen, Gelderland, Netherlands; 3PAMM, Eindhoven, Netherlands; 4Radiology, UMC St Radboud, Netherlands

Endothelial Growth Factor Receptor amplification in high-grade glioma is associated with unfavorable prognosis. The aim of our study was to improve non-invasive identification of EGFR amplification in gliomas by MRS. We collected 76 biopsies from 35 patients with a high grade glioma. A preoperative proton 3D multivoxel MRS scan, semi-LASER sequence with an echo time of 30ms, was performed at 3 Tesla. The EGFR status was determined by MLPA in 31 patients. The concentration of glutamine was significantly correlated with EGFR copy number (sensitivity and specificity 100%) and EGFR variant III (sensitivity 100%, specificity 87%).

Keywords

able absence activity amplification background barker biomedicine biopsies boots brain central characterization chemical clinics collected communication comparable concentration concentrations constants converted copy correlated coupling course dependent detect detected detection determined diagnosis diffuse divided either elucidation endothelial features gain genetic glutamate grade growth identified identifies improve in vivo international invasive lacking laser life ligation like literature materials mature mediator metabolic metabolites molecular multiplex nature neoplasms nervous neuron neurosurgery north particular pathology patients preoperative presence probe prognosis progression promising proton radiology receptor reported scanner semi sensitivity short significantly similarly specificity spectroscopy status story suffering system threshold timing tool tumors unfavorable uptake variant versus young